Suven Life Sciences Limited (BOM:530239)

Suven Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 9, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	51,389	21,742	10,570	13,484	8,961	2,724
Market Cap Growth	58.69%	105.69%	-21.61%	50.48%	228.97%	-91.80%
Enterprise Value	50,789	19,870	10,468	13,313	8,934	2,406
Last Close Price	235.65	99.70	48.47	85.47	64.87	19.72
Forward PE	-	3.65	3.65	3.65	3.65	1.59
PS Ratio	678.49	185.94	77.75	112.83	63.67	18.52
PB Ratio	26.67	8.05	2.82	14.03	8.30	1.90
P/TBV Ratio	26.70	8.06	2.82	14.06	8.31	1.90
PEG Ratio	-	0.13	0.13	0.13	0.13	0.08
EV/Sales Ratio	-	169.93	77.00	111.40	63.48	16.36
Debt / Equity Ratio	0.00	0.00	0.00	0.03	0.04	0.04
Asset Turnover	-	0.04	0.06	0.10	0.09	0.06
Inventory Turnover	-	2.30	27.66	9.10	0.26	0.09
Quick Ratio	-	18.01	21.03	7.13	3.42	0.68
Current Ratio	-	18.99	22.61	8.01	6.45	2.49
Return on Equity (ROE)	-	-32.56%	-50.17%	-119.51%	-57.41%	-49.27%
Return on Assets (ROA)	-	-24.91%	-33.21%	-66.72%	-33.54%	-30.77%
Return on Capital (ROIC)	-37.09%	-25.92%	-34.65%	-74.38%	-39.72%	-38.17%
Earnings Yield	-2.79%	-4.83%	-11.19%	-9.05%	-8.05%	-34.59%
FCF Yield	-	-5.31%	-11.25%	-10.93%	-11.42%	-50.28%
Dividend Yield	-	-	-	1.17%	-	-
Buyback Yield / Dilution	-0.21%	-22.31%	-32.29%	-5.88%	-	-
Total Shareholder Return	-	-22.31%	-32.29%	-4.71%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.